Chronic ambulatory outpatients and four-vector management

American Journal of Managed Care

Volumn 4, Issue 1 SUPPL., 1998, Pages

  Petty, Richard ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT;

AMBULATORY CARE; CONFERENCE PAPER; DRUG EFFICACY; DRUG USE; HUMAN; MANAGED CARE; PRIORITY JOURNAL; SCHIZOPHRENIA; UNITED STATES;

EID: 0031827079     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (6)

1. Schooler NR, Keith SJ, Severe JB, et al. Relapse and rehospitalization during maintenance treatment of schizophrenia: The effects of dose reduction and family treatment. Arch Gen Psychiatry 1997;54:453-463.
2. Zimbroff DL, Kane JM, Tamminga CA, et al, for the Sertindole Study Group. Controlled, dose-response study of sertindole and haloperidol in the treatment of schizophrenia. Am J Psychiatry 1997;154:782-791.
3. Tandon R, Mann NA, Eisner, Coppard N. Effect of anticholinergic medication on positive and negative symptoms in medication-free schizophrenic patients. Psychiatry Research 1990;31:235-241.
4. Tandon R, DeQuardo JR, Goodson J, Mann NA, Greden JF. Effect of anticholinergics on positive and negative symptoms in schizophrenia. Psychopharmacol Bulletin 1992;28:297-302.
5. De Leon J, Odom-White A, Stanilla J, Josiassen R, Simpson GM. Does clozapine induce akathisia? Schizophrenia Research 1995;15:206.
6. Levinson DF, Simpson GM, Singh H, et al. Fluphenazine dose, clinical response, and extrapyramidal symptoms during acute treatment. Arch Gen Psychiatry 1990;47: 761-768.